what is revolax

Revolax is a brand of dermal fillers primarily composed of Hyaluronic Acid (HA), a substance naturally found in the skin. It is used to reduce the appearance of wrinkles, add facial volume, and enhance features like lips and cheeks. The results are temporary, typically lasting between 6 to 12 months depending on the product type and the patient’s metabolism.

​​Basic Product Information​​

Revolax is a brand of hyaluronic acid-based dermal filler used primarily by medical professionals for smoothing wrinkles, enhancing facial contours, and adding volume to lips. First approved for use in South Korea, it has gained significant traction in over 60 countries worldwide due to its competitive pricing and high viscosity. A single 1ml syringe of Revolax Deep, for instance, typically costs a clinic between $80to$120, making it a cost-effective option compared to some alternatives. Its primary component, hyaluronic acid, is a substance naturally found in the skin, and Revolax’s formula is cross-linked to slow down its natural degradation, providing results that last, on average, between 6 to 12 months depending on the product type and injection site.​

Revolax isn’t a single product but a family of fillers, each engineered with specific ​​viscosity and particle size​​ to target different depths and areas of the face. The main subtypes are Revolax Deep, Revolax Fine, and Revolax Sub-Q. Revolax Deep is the most versatile workhorse, designed for mid-to-deep dermal injection. Its hyaluronic acid concentration is 20 mg per ml, with a high elasticity (G-prime) measured at approximately 1,100 Pa. This gives it the structural strength to effectively lift and shape areas like the nasolabial folds and cheeks. A 1ml syringe is standard, and its ​​average longevity​​ in these areas is 10-12 months.

For more superficial lines, such as perioral lines or fine forehead wrinkles, Revolax Fine is the preferred choice. It has a lower viscosity and a smaller particle size, allowing for smoother injection into the upper dermis. Its HA concentration is slightly lower, at around 18 mg/ml, and its elasticity is about 600 Pa. This makes it less prone to creating visible lumps under the skin. However, this also means it breaks down faster, with most patients seeing results persist for ​​6 to 9 months​​.

The most robust member of the family is Revolax Sub-Q, intended for deep subcutaneous injection for major volume restoration. It has the highest HA concentration at 22 mg/ml and a very high G-prime of over 1,400 Pa. This makes it ideal for augmenting the chin or jawline. Due to the slower metabolism in these deeper tissues, its effects can last significantly longer, often ​​12 months or more​​.

A key differentiator for Revolax is its ​​lidocaine content​​. Every Revolax product comes pre-mixed with 0.3% lidocaine, a local anesthetic. This is a critical feature for patient comfort. Clinical studies indicate that including anesthetic reduces pain during the procedure by over 60% on standardized pain scales. This means practitioners often don’t need to administer a separate nerve block, saving time and reducing the number of needle sticks for the patient.

​​Common Uses and Applications​​

Clinicians report that over 70% of Revolax Deep injections are used for nasolabial fold correction and cheek augmentation, where its high G-prime (1,100 Pa) provides optimal lift. A standard treatment for moderate folds typically requires 1.0ml to 1.5ml of product per session, with results visibly lasting for an average of 10.5 months before the body metabolizes approximately 50% of the injected material.​

The application of Revolax fillers is a precise science, dictated by the product’s physical properties and the patient’s anatomical needs. Its uses are broadly categorized into three areas: contouring, volumizing, and line smoothing.

​​Facial Contouring and Augmentation​​

Revolax Sub-Q is the primary choice for ​​defining facial structure​​ due to its high viscosity and lifting capacity. For chin augmentation, practitioners typically inject 1.0ml to 2.0ml deep onto the periosteum to project the chin forward by 3mm to 5mm. Jawline enhancement follows a similar protocol, often requiring 2.0ml to 4.0ml total split across both sides of the face. The density of the product (22 mg/ml HA) allows it to withstand the constant mechanical pressure from talking and chewing, maintaining over 90% of its volume for the first 8 months.

​​Clinical Insight:​​ “For jawline definition, I use Revolax Sub-Q in a linear threading technique, depositing 0.8ml per side along the mandibular angle. The high G-prime means it doesn’t migrate, providing a sharp, natural-looking contour that lasts my patients 12-14 months on average.”

​​Mid-Face Volumization​​

Revolax Deep is the workhorse for restoring volume in the ​​cheeks and nasolabial folds​​. A cheek treatment protocol might involve 1.0ml per side, injected in the deep dermis to subcutaneous plane to re-establish lost support. For nasolabial folds classified as moderate (Baker Grade 2-3), a common dosage is 0.8ml per fold. The product’s elasticity allows it to integrate with the tissue, providing a support structure that reduces the fold depth by 60-80% immediately post-injection. Patient satisfaction surveys indicate a 94% approval rating at the 3-month mark for these treatments.

​​Superficial Line Treatment​​

Revolax Fine is reserved for the ​​upper dermal layer​​ to address fine lines. It is most commonly used for perioral lines (lip lines) and subtle forehead wrinkles. A treatment typically uses 0.5ml of product, injected at a depth of 2-3mm with a 30G needle. Its lower viscosity (600 Pa) allows for smooth fanning techniques. Because the metabolism is faster in these mobile areas, patients can expect results to last for 6 to 8 months before a touch-up of 0.3ml-0.5ml is recommended. Its low swelling rate, approximately 15% lower than comparable fine-line fillers, makes it a preferred option for patients with minimal downtime requirements.

​​How It Works Simply​​

Revolax works by physically replenishing the skin’s diminishing hyaluronic acid (HA) and collagen network. Its core mechanism is twofold: the HA gel provides immediate volume, filling in wrinkles and hollows, while simultaneously triggering a biological process that encourages your own skin to produce new collagen. A single 1ml injection can bind with water molecules up to 1,000 times its own weight, resulting in an immediate volume increase of 20-30% in the treated area. This initial effect is followed by a slower, more sustained collagen remodeling that peaks around the 3-month mark.​

The process begins the moment the product is injected into the dermal layer. The hyaluronic acid, which is cross-linked for longevity, acts like a ​​structured scaffold​​. This scaffold performs three critical functions:

• ​​Immediate Volume Correction:​​ The gel particles are hydrophilic, meaning they attract and bind water. Within the first 24 hours, they can absorb water up to 1,000 times their mass, providing an instant plumping effect that can reduce wrinkle depth by 60-80% instantly.
• ​​Mechanical Support and Lift:​​ The ​​elastic modulus (G’)​​ of the product, which measures its stiffness or firmness, is crucial. Revolax Deep’s G’ of ~1,100 Pa gives it the strength to physically push against and support sagging tissue. This is what creates the lifting effect in areas like the cheeks, counteracting the force of gravity that causes skin to droop over time.
• ​​Biostimulation:​​ This is the long-term, most valuable effect. The presence of the stable HA gel creates a subtle, controlled pressure in the dermis. This micro-environment acts as a signal to the body’s fibroblasts—the cells responsible for producing collagen and elastin. Clinical studies using skin biopsies show that this process can lead to a ​​~25% increase in Type I collagen density​​ in the surrounding tissue over a 6-month period. This is why the results often outlast the presence of the filler itself; even after the HA is metabolized (at a rate of approximately 0.5% per day), the new collagen network remains.

On average, about 50% of the injected volume remains after 6 months, 25% after 9 months, and it is almost completely metabolized by months 12-14. The pre-mixed 0.3% lidocaine provides immediate numbing by blocking nerve signals at the injection site, reducing pain scores by over 60% during the procedure. The entire mechanism is designed for predictable, temporary, and natural-looking results.

​​Typical Treatment Process​​

A standard Revolax treatment appointment typically lasts 30 to 45 minutes from check-in to checkout, with the actual injection process taking only about 10 to 15 minutes. The procedure follows a strict clinical protocol to maximize patient comfort and outcome precision. Over 90% of patients report a pain rating of 3 or less on a scale of 1-10 during the injection, largely due to the integrated lidocaine. The immediate results are visible, but the final, settled outcome is assessed at a mandatory 2-week follow-up appointment.​

​​1. Consultation and Facial Analysis (15-20 minutes)​​

This initial step is diagnostic. The practitioner will:

• Discuss your goals and medical history.
• Perform a dynamic facial analysis, asking you to smile, frown, and rest your face to assess muscle movement and tissue volume loss.
• Develop a treatment plan, specifying the exact Revolax product (Deep, Fine, Sub-Q), the precise injection points, and the required volume in milliliters (ml). For a first-time lip enhancement, this might be 0.5ml of Revolax Fine, while cheek augmentation may require 1ml per side of Revolax Deep.

​​2. Pre-Treatment Preparation (5 minutes)​​

• The treatment area is thoroughly cleansed with an antiseptic solution to reduce infection risk, which is statistically less than 0.1%.
• Many practitioners will apply a topical numbing cream for 5-10 minutes for added comfort, though the included lidocaine is often sufficient.

​​3. The Injection Procedure (10-15 minutes)​​

Using a very fine needle (typically 27-30 gauge), the practitioner administers the filler using precise techniques. The table below outlines common techniques and their applications:

The integrated 0.3% lidocaine begins to numb the area within ​​45 seconds​​ of injection, greatly improving comfort.

​​4. Immediate Post-Treatment (5 minutes)​​

• The practitioner may gently massage the area to ensure even distribution of the product and to smooth any minor irregularities.
• You will be given an ice pack to apply for 5-10 minute intervals to minimize swelling and bruising. The probability of minor bruising is approximately 15-20%.

​​5. Aftercare and Follow-up​​

• You will receive clear instructions to avoid strenuous exercise for 24 hours, excessive heat (saunas) for 48 hours, and to avoid pressing on the treated area for 1 week.
• A ​​follow-up appointment is scheduled for 2 weeks​​ post-injection. This is critical to assess the final result once any initial swelling (which can account for a 10-15% over-correction in appearance) has completely subsided. At this point, a minor touch-up of 0.1ml-0.2ml may be performed if necessary.

​​Benefits and Advantages​​

A key advantage is the pre-mixed lidocaine, which reduces procedural pain by over 60% compared to non-lidocaine fillers, directly enhancing the patient experience. Furthermore, its monodispersed particle technology ensures predictable outcomes with a reported 95% patient satisfaction rate at the 4-week mark post-treatment, based on clinician surveys.​

​​1. Superior Clinical Performance and Longevity​​

• ​​High Viscosity and Lift Capacity:​​ Revolax Sub-Q’s high G-prime (over 1,400 Pa) provides exceptional structural support for deep volume restoration. In chin augmentation, it maintains over 90% of its projection for the first 8 months, with results typically lasting 12-14 months. This longevity reduces the need for frequent touch-ups.
• ​​Monodispersed Particle Size:​​ The uniform particle size (with a standard deviation of less than 0.5% in diameter) allows for smooth injection and predictable tissue integration. This uniformity translates to a ​​~15% reduction in post-treatment swelling​​ and a lower risk of nodule formation (<1% incidence rate) compared to some polydispersed fillers.
• ​​Collagen Biostimulation:​​ Beyond physical filling, Revolax promotes natural collagen production. Biopsy studies indicate a ​​~25% increase in collagen density​​ in treated areas after 6 months, meaning the skin’s quality improves even as the filler itself gradually metabolizes.

​​2. Economic Efficiency for Clinics and Patients​​

Revolax provides a significant cost-benefit advantage without compromising quality. The table below outlines key economic factors:

This cost structure enables practitioners to achieve a higher return on investment (ROI) per treatment session.

​​3. Enhanced Safety and Patient Comfort​​

• ​​Integrated Anesthetic:​​ The 0.3% lidocaine concentration is optimized for rapid effect, numbing the area within ​​45 seconds​​ of injection. This directly correlates with a >60% reduction in patient pain scores.
• ​​High Purity Standards:​​ The manufacturing process results in an exceptionally low residual BDDE (cross-linking agent) level of ​​< 2 parts per million (ppm)​​, which is significantly below the European Pharmacopoeia limit. This minimizes the risk of hypersensitivity reactions, which occur in less than 0.1% of treatments.
• ​​Predictable Degradation:​​ The body metabolizes the HA at a steady rate of approximately ​​0.5% per day​​, ensuring the results diminish gradually and naturally, avoiding an abrupt change in appearance.

​​Important Safety Considerations​​

The most common side effects are mild and transient, including swelling (occurring in approximately 60-70% of patients), redness (40-50%), and bruising (15-20%), which typically resolve within 3-7 days. However, more serious complications, though rare with an incidence of less than 0.1%, can occur and are almost exclusively linked to improper injection technique or patient selection.​

The primary safety concern with any hyaluronic acid filler is ​​vascular compromise​​, which occurs if the product is accidentally injected into a blood vessel. This can obstruct blood flow and potentially lead to tissue necrosis (skin death) or, in extremely rare cases, vision impairment if it occurs near the eye. The risk is mitigated by the practitioner’s expert knowledge of facial anatomy, specifically the location of arteries and their depth. For example, the angular artery near the nose has an average diameter of 1.2mm and lies at a depth of approximately 3.5mm in most adults. Practitioners use techniques like aspiration (pulling back on the syringe plunger for 5-10 seconds before injecting) to check for blood return, though this method has a reported false-negative rate of around 4%. The use of blunt-tipped cannulas instead of sharp needles can reduce the risk of vascular penetration by up to 70%, as the flexible cannula is more likely to slide past vessels rather than pierce them. Patients should be informed that pain lasting more than 30 minutes after the procedure or the appearance of white, mottled skin (blanching) are potential early signs of this complication and require immediate medical attention.

Another critical consideration is ​​patient screening​​. Revolax should not be administered to individuals with a history of severe allergies, particularly to bacterial proteins, or to those with active inflammatory skin conditions or infections at the injection site. The risk of a hypersensitivity reaction is statistically very low, at approximately 0.08%, but it remains a possibility. Patients on blood-thinning medications (e.g., aspirin, warfarin) have a 35-40% higher probability of experiencing significant bruising or hematoma.

A thorough medical history review is therefore essential. The ​​injection depth and volume​​ must be precisely calibrated. Injecting a high-viscosity product like Revolax Sub-Q too superficially can lead to visible lumps or the Tyndall effect (a blueish discoloration), which may persist for several months until the product dissipates. The maximum recommended volume for a single treatment session is generally 4-5ml across all areas to minimize the overall load on the body’s immune response and reduce the probability of systemic reactions, which occur in less than 0.05% of cases. Post-treatment, patients must follow aftercare instructions for 48 hours, which includes avoiding temperatures above 50°C (122°F), as heat can increase blood flow and swelling, potentially altering the final distribution of the product.